The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats

Cuperus FJC, Hafkamp AM., Havinga R, Vitek L, Zelenka J, Tiribelli C, Ostrow JD, Verkade HJ.

Gastroenterology Feb, 136:673-682.

2009

Long-term evaluation of glucose homeostasis in a cohort of HAART treated HIV-infected children

Viganò A, Brambilla P, Pattarino G, Stucchi S, Fasan S, Raimondi C, Cerini C, Giacomet V, Zuccotti GV, Bedogni G.

Clinical Drug Investigation ;Feb; 29:101-109

2009

The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1

Corich L, Aranda A, Carcassa L, Bellarosa C, Ostrow JD and Tiribelli C.

Biochem J, Jan, 417:305-321

2009

Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls

Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, Rosina F, Marzioni M, Fabris, Muratori L, Qi L. Seldin MF, Gershwin ME, Podda M, and the Italian PBC Genetic Study Group (including Tiribelli C).

Hepatology, Dec, 48:1906-1912

2008

Differential expression of the multidrug-resistance associated proteins ABCb1 and ABCc1 between blood-brain interfaces

Gazzin S, Strazielle N, Schmitt C, Fèvre-Montange M, Ostrow JD, Tiribelli C, Ghersi-Egea JF.

J Comp Neurol, Oct, 510:497-507

2008

Compliance alla dieta nell’insufficienza renale cronica [Compliance with low-protein diet in patients with chronic kidney disease]

Bellizzi V, Bedogni G, Quintaliani S.

Giornale Italiano di Nefrologia, Sep-Oct;25:45-49

2008

Natural course of chronic HCV and HBV infection and role of alcohol in the general population: The Dionysos study

Bedogni G, Miglioli L, Masutti F, Ferri S, Castiglione A, Lenzi M, Crocè LS, Granito A, Tiribelli C, and Bellentani S.

Amer J Gastroenterol, Sep, 103:2248-2253

2008

Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis

Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, Comparcola D, Piemonte F, Nobili V.

Gut, Sep:57:1283-1287

2008

Transcutaneous bilirubin measurements: useful, but also reproducible?

Dani C, Hulzebos CV, Tiribelli C

Pediatr Res. 2020. doi: 10.1038/s41390-020-01242-3.

2020

Elastography: where are we now?

Giuffré M, Colecchia A, Crocé LS

Minerva Gastroenterol Dietol. 2020. doi: 10.23736/S1121-421X.20.02773-7.

2020

The role of bilirubin and other “yellow players” in neurodegenerative diseases

Jayanti S, Vitek L, Tiribelli C, Gazzin S

Antioxidants. 9(9):900. doi: 10.3390/antiox9090900.

2020

Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation

Vítek L, Tiribelli C

N Engl J Med 2020 Aug 13;383(7):684-686.doi: 10.1056/NEJMcibr2013250.

2020

HCC occurrence after DAA treatments: Molecular tools to assess the post-treatment risk and surveillance

Pascut D, Pratama MY, Tiribelli C

Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010

2020

Sorafenib resistance in hepatocellular carcinoma: The relevance of genetic heterogeneity

Cabral KL, Tiribelli C, Sukowati CHC

Cancers (Basel). 2020 Jun 15;12(6):E1576. doi: 10.3390/cancers12061576.

2020

Charles E. Ahlfors (1944–2020)

Wennberg RP, Wong RJ, Shapiro SM, Tiribelli C

Pediatr Res. 2020 May 6. doi: 10.1038/s41390-020-0938-y.

2020

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

Eslam M, Sanyal AJ, George J, on behalf of an international consensus panel (including Tiribelli C)    

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312.

2020

A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature

Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS

Am J Physiol Gastrointest Liver Physiol.318(5):G889-G906 doi: 101152/ajpgi001612019

2020

Sex differences in Non-Alcoholic Fatty Liver Disease: Hints for future management of the disease

Salvoza NC, Giraudi PJ, Tiribelli C, Rosso N

Explor Med. 2020;1:51-74 DOI: https://doi.org/10.37349/emed.2020.00005

2020